Hwaseong, South Korea

Tae Hun Song

This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: Hanmi Science Co., Ltd., Hanmi Pharm. Co., Ltd.. Active years: 2013-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tae Hun Song. Retrieved from https://idiyas.com/inventor/tae-hun-song

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


Average Co-Inventor Count = 10.9

ph-index = 2

Forward Citations = 14(Granted Patents)


Location History:

  • Yongin-si, KR (2013)
  • Hwaseong-si, KR (2018)

Company Filing History:


Years Active: 2013-2018

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovator Spotlight: Tae Hun Song

Introduction

Tae Hun Song, a prominent inventor based in Hwaseong-si, South Korea, has made significant contributions to the field of pharmaceutical science with his inventive spirit and dedication. With two patents to his name, he has displayed a keen ability to address complex biological challenges through innovative solutions.

Latest Patents

Tae Hun Song’s latest patents include the following groundbreaking inventions:

1. **Bicyclic heteroaryl derivatives having inhibitory activity for protein kinase** - This invention relates to a novel bicyclic heteroaryl derivative, along with its pharmaceutically acceptable salts, hydrates, and solvates. This compound shows improved inhibitory activity for protein kinases and a pharmaceutical composition aimed at preventing or treating abnormal cell growth disorders.

2. **Insulinotropic complex using an immunoglobulin fragment** - This patent introduces an insulinotropic peptide conjugate designed to enhance the in-vivo duration of efficacy and stability. It comprises an insulinotropic peptide, a non-peptide polymer, and an immunoglobulin Fc region, all covalently linked. This innovative conjugate maintains a relatively high in-vivo activity and significantly increases blood half-life, making it advantageous for developing long-acting formulations of various peptide drugs.

Career Highlights

Tae Hun Song has contributed his expertise to notable companies including Hanmi Science Co., Ltd. and Hanmi Pharmaceutical Co., Ltd. His work in these organizations has allowed him to develop his pivotal inventions that advance medical technology and improve patient outcomes.

Collaborations

Throughout his career, Tae Hun has collaborated with talented colleagues such as Dae Hae Song and Chang Ki Lim. These partnerships have proven valuable in the innovation process, enabling the development of effective therapeutic solutions.

Conclusion

Tae Hun Song stands out as an influential inventor in the field of pharmaceuticals. His innovative patents reflect a deep understanding of biological systems and a commitment to enhancing therapeutic efficacy. With continued dedication to his work, there is no doubt that he will further contribute to the realm of medical science in the years to come.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…